# Internal Review — Round 1

## PART 1: CRITICAL REVIEW

### Identification
The continuous-treatment DiD using pre-war Russian gas dependence as treatment intensity is credible. Gas dependence in 2021 is plausibly exogenous to post-2022 mortality shocks. The parallel trends assumption is supported by the event study (Figure 2) showing flat pre-trends. The first stage (9.92 pp higher energy price growth) is strong and statistically significant.

### Inference
Standard errors clustered at the country level (26 clusters) are the main concern. The paper addresses this with wild cluster bootstrap (p=0.63) and randomization inference (p=0.64), both confirming the null. Sample sizes are coherent across specifications.

### Robustness
Summer placebo, pre-COVID winter placebos, leave-one-out, and dose-response analyses all corroborate the null. The event study provides visual confirmation.

### Key Weaknesses
1. Age-specific analysis uses raw death counts rather than age-specific rates, limiting interpretability
2. Excess deaths specification restricts to 2018-2024 — the rationale could be sharper
3. The paper documents a null but the fiscal policy mechanism is largely argued by exclusion

## PART 2: CONSTRUCTIVE SUGGESTIONS

1. The SDE table in the appendix should clearly report the classification (null)
2. Consider discussing the timing of fiscal interventions more precisely — when did price caps take effect relative to heating seasons?
3. The conclusion could more explicitly discuss what data would be needed to directly test the fiscal mechanism

## OVERALL ASSESSMENT

- **Strengths:** Clean identification, strong first stage, comprehensive robustness, well-written prose
- **Weaknesses:** Null result limits publishability; fiscal mechanism is argued by exclusion
- **Publishability:** Competitive working paper; the null is informative and well-characterized

DECISION: MINOR REVISION
